Biocept Stock Predictions

Healthcare > Medical - Diagnostics & Research

Buy BIOC

*Your capital is at risk

$0.435

+0 (+0%)

At Close: Jan 23, 2024

Currently predicting for Mon, 8 Jun 2026

BIOC Prediction Chart

BIOC Predictions History

Latest community submissions for BIOC.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
YoungBulls	Jan 19, 2017	$1.61 -2.42%	$1.65	X	97.60%	0
Harikumar.Bhavan.2032	Jan 19, 2017	$1.59 -3.64%	$1.65	X	96.40%	0
Abdu Pro @Abdu.1501	Dec 12, 2016	$0.92 -1.08%	$0.93	X	98.90%	1
JS Pro	Dec 12, 2016	$0.91 -2.04%	$0.93	X	98.00%	0
Jordan.Barnes.1814	Dec 12, 2016	$0.92 -1.61%	$0.93	X	98.40%	0
mrcriter	Aug 23, 2016	$0.610 -68.72%	$0.650	V	93.80%	0
StockInvest Amateur	Aug 15, 2016	$0.580 -61.33%	$0.500	V	84.00%	0
Stockdum Senior	May 18, 2016	$0.740 -65.58%	$0.720	V	97.20%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BIOC with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BIOCEPT

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The compa...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by